Faculty

Needs Statement

Previously, coronary heart disease was managed as a mechanical problem whose occurrence and progression were considered inevitable.  There is now excellent evidence for an association with abnormal metabolism and inflammation.  In addition, there are good clinical outcomes data that therapeutic lifestyle changes and medications that alter these abnormalities decrease the incidence of coronary heart disease events.  Therefore, there is a major need to increase practicing physician and patient awareness that much can be offered to decrease disease risk.

Target Audience

Physicians

Objectives

1. Summarize basic data supporting the benefit of cholesterol reduction;
2. Discuss the latest concepts in the treatment of cholesterol, LDL, triglycerides and HDL, plus emphasize the cholesterol treatment gap;
3. Identify problems with certain pharmaceuticals including what is innovative and of value versus what is marketing;
4. Interrelate the importance of inflammatory risk factors in coronary heart disease management.
5. Discuss future directions in coronary heart disease prevention;
6. Consider the nature and prevalence of the metabolic syndrome in the spectrum of coronary heart disease.

Accreditation

CME
The University of Kentucky College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Kentucky College of Medicine designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The University of Kentucky College of Medicine presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field.

Faculty Disclosure

Dr. Whayne reports no relevant financial relationships with commercial interests of healthcare products or services related to this activity.